Literature DB >> 5212345

Maintenance of sinus rhythm after atrial defibrillation.

P Szekely, D A Sideris, G A Batson.   

Abstract

The long-term results of 356 episodes of atrial defibrillation by DC shock carried out in 250 patients are reviewed. In 78 per cent of the cases, atrial fibrillation recurred by the end of 12 months in spite of the administration of quinidine or procainamide or propranolol, singly or combined. However, when no antidysrhythmic drugs were used the recurrence rate was higher at all periods of observation and 100 per cent at the end of 12 months. The difference in the overall results between the untreated group and the treated groups with the exception of the propranolol group is significant (p less than 0.05). In addition, the propranolol group showed an obviously reduced recurrence rate at 1 month, but afterwards the results tended to approximate those in the untreated group. The period during which sinus rhythm could be maintained in patients who underwent valve operations was on the whole the same as in patients who did not have heart surgery. However, in a small number of patients sinus rhythm was maintained for longer periods after mitral valve replacement than before it. Sinus rhythm was maintained for significantly longer periods when atrial fibrillation lasted less than 1 year than when it had been present for more than 1 year (p less than 0.001). It is concluded that there is justification for a judicious antidysrhythmic prophylaxis after atrial defibrillation.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5212345      PMCID: PMC487406          DOI: 10.1136/hrt.32.6.741

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  12 in total

1.  PROPRANOLOL IN ATTEMPTED MAINTENANCE OF SINUS RHYTHM AFTER ELECTRICAL DEFIBRILLATION.

Authors:  T C TSOLAKAS; J P DAVIES; S ORAM
Journal:  Lancet       Date:  1964-11-14       Impact factor: 79.321

2.  TREATMENT OF ATRIAL FIBRILLATION AFTER SURGICAL REPAIR OF THE MITRAL VALVE.

Authors:  A SELZER; J J KELLY; F GERBODE; W J KERTH; J E BLACKLEY; J J MORGAN; K KEYANI
Journal:  Ann Intern Med       Date:  1965-06       Impact factor: 25.391

3.  Conversion of atrial fibrillation to sinus rhythm by direct-current shock.

Authors:  S ORAM; J P DAVIES; I WEINBREN; P TAGGART; L D KITCHEN
Journal:  Lancet       Date:  1963-07-27       Impact factor: 79.321

4.  Lupus-like syndrome induced by procainamide.

Authors:  A M Fakhro; R F Ritchie; B Lown
Journal:  Am J Cardiol       Date:  1967-09       Impact factor: 2.778

5.  Quinidine prior to direct current countershock--a medical hazard.

Authors:  H Aberg
Journal:  Acta Med Scand       Date:  1969-09

6.  An evaluation of DC shock treatment of atrial arrhythmias.

Authors:  C Bjerkelund; O M Orning
Journal:  Acta Med Scand       Date:  1968-12

7.  Appraisal of electroconversion in treatment of cardiac dysrhythmias.

Authors:  L Resnekov; L McDonald
Journal:  Br Heart J       Date:  1968-11

8.  Use of long-acting quinidine in maintaining sinus rhythm after electroconversion of atrial dysrhythmias.

Authors:  L Resnekov; S Waich; D Gibson; L McDonald
Journal:  Br Heart J       Date:  1969-05

9.  Direct current conversion of atrial fibrillation--long-term results.

Authors:  H Aberg; I Cullhed
Journal:  Acta Med Scand       Date:  1968-11

10.  Prognosis of atrial arrhythmias treated by electrical counter shock therapy. A three-year follow-up.

Authors:  C McCarthy; P J Varghese; D W Barritt
Journal:  Br Heart J       Date:  1969-07
View more
  11 in total

1.  New deal for old hearts.

Authors:  O M Jolobe
Journal:  BMJ       Date:  1991-08-10

2.  Prospective randomized trial of external versus internal transcatheter cardioversion in patients with chronic atrial fibrillation.

Authors:  K E Paravolidakis; T M Kolettis; G N Theodorakis; I A Paraskevaidis; T S Apostolou; D T Kremastinos
Journal:  J Interv Card Electrophysiol       Date:  1998-09       Impact factor: 1.900

Review 3.  Risk-benefit assessment of amiodarone in the treatment of cardiac arrhythmias.

Authors:  P J Counihan; W J McKenna
Journal:  Drug Saf       Date:  1990 Jul-Aug       Impact factor: 5.606

4.  Combined treatment of atrial fibrillation with quinidine and beta-blockers.

Authors:  G F Levi; C Proto
Journal:  Br Heart J       Date:  1972-09

5.  Pathology of atrial fibrillation in man.

Authors:  M J Davies; A Pomerance
Journal:  Br Heart J       Date:  1972-05

6.  Effect of quinidine on maintaining sinus rhythm after conversion of atrial fibrillation or flutter. A multicentre study from Stockholm.

Authors:  T Södermark; B Jonsson; A Olsson; L Orö; H Wallin; O Edhag; A Sjögren; M Danielsson; G Rosenhamer
Journal:  Br Heart J       Date:  1975-05

Review 7.  Adverse effects of antiarrhythmic drugs.

Authors:  J B Schwartz; D Keefe; D C Harrison
Journal:  Drugs       Date:  1981-01       Impact factor: 9.546

8.  Persistent lone atrial fibrillation--its prognosis after clinical diagnosis.

Authors:  J B Close; D W Evans; S M Bailey
Journal:  J R Coll Gen Pract       Date:  1979-09

Review 9.  Atrial fibrillation pearls and perils of management.

Authors:  P J Kudenchuk
Journal:  West J Med       Date:  1996-05

10.  Peak Early Diastolic Transmitral Velocity As A Surrogate Marker Of Short-Term Atrial Fibrillation Recurrence After Electrical Cardioversion.

Authors:  Christos Varounis; Themistoklis Maounis; Dennis V Cokkinos
Journal:  J Atr Fibrillation       Date:  2015-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.